- Report
- May 2025
- 565 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 386 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 478 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 392 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 176 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 479 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 74 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 269 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 284 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 64 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 553 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 381 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 80 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 287 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 285 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 250 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 1417 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 182 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 88 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 89 Pages
Global
From €5355EUR$5,850USD£4,551GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more